Invention Grant
- Patent Title: Use of allogeneic interstitial vessel-layer cell and allogeneic mesenchymal progenitor cell for preventing or treating osteoarthritis
-
Application No.: US15947231Application Date: 2018-04-06
-
Publication No.: US10751371B2Publication Date: 2020-08-25
- Inventor: Wei Cao , Xiaoling Zeng , Mohammad Abdul Kaium , Yujie Zhou
- Applicant: CELLULAR BIOMEDICINE GROUP (SHANGHAI) LTD. , CELLULAR BIOMEDICINE GROUP (WUXI) LTD.
- Applicant Address: CN Shanghai CN Wuxi, Jiangsu
- Assignee: Cellular Biomedicine Group (Shanghai) Ltd.,Cellular Biomedicine Group (Wuxi) Ltd.
- Current Assignee: Cellular Biomedicine Group (Shanghai) Ltd.,Cellular Biomedicine Group (Wuxi) Ltd.
- Current Assignee Address: CN Shanghai CN Wuxi, Jiangsu
- Agency: Hamre, Schumann, Mueller & Larson, P.C.
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@3fa1709a
- Main IPC: A61K35/28
- IPC: A61K35/28 ; A61K35/44 ; A61K38/20 ; A61K38/18 ; A61K38/19
Abstract:
Provided are uses of allogeneic interstitial vessel-layer cells and allogeneic mesenchymal progenitor cells in the preparation of a pharmaceutical composition for preventing or treating osteoarthritis (OA). Also provided is a pharmaceutical composition containing the allogeneic interstitial vessel-layer cells and the allogeneic mesenchymal progenitor cells.
Public/Granted literature
Information query
IPC分类:
